pyrroles has been researched along with chicoric acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beale, K; King, PJ; Lee, DJ; Reinke, RA; Robinson, WE; Victoria, JG | 1 |
| Johnson, AA; Marchand, C; Pommier, Y | 1 |
| King, PJ; Lee, DJ; Lei, X; Mao, Y; McDougall, BR; Reinecke, MG; Reinke, RA; Robinson, WE; Victoria, J | 1 |
1 review(s) available for pyrroles and chicoric acid
| Article | Year |
|---|---|
HIV-1 integrase inhibitors: a decade of research and two drugs in clinical trial.
Topics: Acetoacetates; Anti-HIV Agents; Biological Factors; Caffeic Acids; Clinical Trials as Topic; Furans; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Indoles; Models, Molecular; Molecular Structure; Oligonucleotides; Pyrroles; Reverse Transcriptase Inhibitors; Succinates; Tetrazoles; Triazoles | 2004 |
2 other study(ies) available for pyrroles and chicoric acid
| Article | Year |
|---|---|
Human immunodeficiency virus type-1 integrase containing a glycine to serine mutation at position 140 is attenuated for catalysis and resistant to integrase inhibitors.
Topics: Acetoacetates; Amino Acid Substitution; Caffeic Acids; Cell Line; Drug Resistance, Viral; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Pyrroles; Reverse Transcriptase Polymerase Chain Reaction; Succinates; Virus Integration; Virus Replication | 2003 |
L-chicoric acid inhibits human immunodeficiency virus type 1 integration in vivo and is a noncompetitive but reversible inhibitor of HIV-1 integrase in vitro.
Topics: Acetoacetates; Binding Sites; Caffeic Acids; Cell Line, Tumor; Dose-Response Relationship, Drug; Echinacea; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Kinetics; Mutation; Polymerase Chain Reaction; Pyrroles; Succinates; Virus Integration | 2004 |